Treatment Outcome of Chinese Children with Anaplastic Large Cell Lymphoma by Using a Modified B-NHL-BFM-90 Protocol

REFERENCES

• Wright D, McKeever P, Carter R. Childhood non hodgkin lymphomas in the united kingdom: findings from the UK children's cancer study group. J Clin Pathol. 1997;50:128–134.
   PubMed Web of Science ®Google Scholar
• Therapy for Childhood ALCL/Rosolen 2139 Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 4th ed. Philadelphia: J.B. Lippincott, 2002.
   Google Scholar
• Sandlund JT, Pui CH, Roberts WM, Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood. 1994; 84: 2467–2471.
   PubMedGoogle Scholar
• Reiter A, Schrappe M, Tiemann M, Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Münster group studies. J Clin Oncol. 1994;12:899–908.
   PubMed Web of Science ®Google Scholar
• Brugières L, Le Deley MC, Pacquement H, CD 30_ anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French society of pediatric oncology. Blood. 1998;92:3591–3598.
   PubMed Web of Science ®Google Scholar
• Abdulkader I, Cameselle-Teijeiro J, Fraga M, Rodriguez- Nunez A, Allut AG, Forteza J. Primary anaplastic large cell lymphoma of the central nervous system. Hum Pathol. 1999;30:978–981.
   PubMed Web of Science ®Google Scholar
• Seidemann K, Tiemann M, Schrappe M, Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Trial NHL-BFM 90. Blood. 2001;97:3699–3706.
   PubMed Web of Science ®Google Scholar
• Rosolen A, Pillon M, Garaventa A, Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer. 2005;104(10):2133–2140.
   PubMed Web of Science ®Google Scholar
• Williams DM, Hobson R, Imeson J, Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol. 2002;117(4):812–820.
   PubMed Web of Science ®Google Scholar
• Lowe EJ, Sposto R, Perkins SL, Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941. Pediatr Blood Cancer. 2009 Mar;52(3):335–339.
   Google Scholar
• Pillon M, Gregucci F, Lombardi A et al. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood. Pediatr Blood Cancer. 2012.;59(5):828–833.
   PubMed Web of Science ®Google Scholar
• Murphy SB. Classification, staging and end results of treatment in childhood non-Hodgkin's lymphoma: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Harris NL, Stein H, Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008, 157–166.
   Google Scholar
• Duyster J, Bai RY, Morris SW. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene. 2001; 20(40):5623–5637.
   PubMed Web of Science ®Google Scholar
• Perkins SL, Pickering D, Lowe EG, Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation. Br J Haematol 2005;131:624–627.
   PubMed Web of Science ®Google Scholar
• Woessmann W, Seidemann K, Mann G, The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005;105(3):948–958.
   PubMed Web of Science ®Google Scholar
• Brugières L, Le Deley MC, Rosolen A, Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group
   Google Scholar
• Williams D, Mori T, Reiter A, Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study. Pediatr Blood Cancer. 2013;60(10):118–121.
   Google Scholar
• Mori T, Takimoto T, Katano N, Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan. Br J Haematol. 2006;132(5):594–597.
   PubMed Web of Science ®Google Scholar
• Woessmann W, Zimmermann M, Lenhard M, Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol. 2011;29(22):3065–3071.
   PubMed Web of Science ®Google Scholar
• Brugières L, Pacquement H, Le Deley MC, Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol. 2009;27(30):5056–5061.
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini C, Messa C, Pogliani EM. Crizotinib in anaplastic large-cell lymphoma. N Engl J Med. 2011;364(8):775–776.
   PubMed Web of Science ®Google Scholar